CD96 and cholangiocarcinoma: Specifically, the CD96 expression level was significantly increased in ACC, BRCA, endocervical adenocarcinoma (CESC), cholangiocarcinoma (CHOL), COAD, ESCA, GBM, HNSC, KIRC, KIRP, acute myeloid leukemia (LAML), LGG, liver hepatocellular carcinoma (LIHC), ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), SKCM, STAD, and testicular germ cell tumors (TGCT).